AdLip: Human Coach-supported Digital/AI Personal Health Assistant to Improve Adherence to Lipid-Lowering Medication

Who May Qualify: - Between 21 to 84 years old - Prescribed statins with or without ezetimibe for hyperlipidaemia. - Medication non-adherence as defined by the \"Extent to Non-adherence\" sub-scale of the DOSE Non-Adherence Measure), with a score \> 1 (range from 0-15) - Singapore residents (citizens, permanent residents, or long-term pass holders). - In possession of a smartphone or tablet with Android or iOS operating systems. - Have internet access on their mobile devices. Who Should NOT Join This Trial: - Does not read or understand English. Current use of smartphone medication adherence app(s) that include statins. - Concurrent use of PCSK9 Inhibitors in addition to statins and/or ezetimibe - Participation in another study that uses medications that could affect lipid levels - Severe renal impairment defined as chronic kidney disease stage 4 and above. - Severe liver disease (Child-Pugh Class C) - Existing muscular-related complaints or diagnoses which may confound adverse event reporting - Uncorrected thyroid conditions, especially poorly-controlled hypothyroidism - Documented psychiatric diagnosis or history of mental illness or deemed as unable to give willing to sign a consent form. - Currently pregnant, breastfeeding or expecting to get pregnant during the course of the study (1 year). - Guarded prognosis with expectant mortality within 12 months or less. Always talk to your doctor about whether this trial is right for you.